PDGFR-β participates in fibroblast activation and transformation (Jansson et al., 2018; Primac et al., 2019) while inhibition of PDGFR signaling could transform CAFs into resting fibroblasts and inhibit angiogenesis and tumor growth (Hu et al., 2022). Here, PDGFRB is linked to neoplasm.